Valuation: Haemonetics Corporation

Market Cap 3.57B 3.12B 2.88B 2.65B 5.01B 344B 5.1B 34.39B 13.51B 168B 13.4B 13.1B 580B P/E 2027 *
20x
P/E 2028 * 17.7x
Enterprise Value 4.24B 3.71B 3.43B 3.15B 5.95B 409B 6.06B 40.88B 16.06B 200B 15.92B 15.57B 689B EV / Sales 2027 *
3.02x
EV / Sales 2028 * 2.68x
Free-Float
98.78%
Yield 2027 *
2.55%
Yield 2028 * -
1 day+2.37%
1 week+4.67%
Current month+4.67%
1 month+5.47%
3 months+30.59%
6 months+8.77%
Current year-2.06%
1 week 73.22
Extreme 73.22
80
1 month 71.81
Extreme 71.81
80
Current year 51
Extreme 51
86.11
1 year 47.32
Extreme 47.315
87.32
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 29.17
Extreme 29.17
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 71 23/07/2014
Director/Board Member 62 16/05/2016
Date Insider Type Main position Quantity % Market Cap.
5/6/26 Tax

VP, Chief Accounting Officer

-259 0.0006%
5/6/26 Tax

Head of Human Resources

-313 0.0007%
15/5/26 Tax

VP, Chief Accounting Officer

-2,417 0.0052%
Change 5-day change 1-year change 3-year change Capi.($)
+2.37%+4.67%+5.50%-6.55% 3.48B
+10.71%+4.69%-24.98%-8.43% 155B
+3.84%+1.42%-6.93%-4.67% 103B
+3.85%+1.83%+3.41%+60.90% 57.7B
+0.08%+1.13%+37.88%+53.70% 52.27B
+3.26%+6.02%-10.29%-38.34% 42.68B
+4.23%+0.64% - - 33.35B
+7.22%+6.79%-7.31%-43.21% 28.06B
+0.96%+1.34%+61.53%-5.89% 25.36B
-0.85%+4.34%-3.58%-18.66% 21.03B
Average +3.56%+3.18%+6.14%-1.24% 52.24B
Weighted average by Cap. +5.33%+2.98%-3.19%+2.28%

Financials

2027 *2028 *
Net sales 1.4B 1.23B 1.13B 1.04B 1.97B 135B 2B 13.51B 5.31B 65.96B 5.26B 5.15B 228B 1.47B 1.29B 1.19B 1.09B 2.07B 142B 2.11B 14.21B 5.58B 69.37B 5.54B 5.41B 239B
Net income 176M 154M 143M 131M 248M 17B 252M 1.7B 668M 8.3B 662M 648M 28.65B 204M 178M 165M 151M 286M 19.64B 291M 1.96B 772M 9.59B 765M 749M 33.11B
Net Debt 672M 588M 544M 499M 944M 64.8B 960M 6.48B 2.55B 31.64B 2.53B 2.47B 109B 385M 336M 311M 285M 540M 37.08B 550M 3.71B 1.46B 18.11B 1.45B 1.41B 62.51B
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
16/07/26 US$78.50 +2.37% 952,048
15/07/26 US$76.68 +3.05% 534,782
14/07/26 US$74.41 -3.23% 650,537
13/07/26 US$76.89 +0.92% 691,162
10/07/26 US$76.19 +1.59% 456,265
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
78.50USD
Average target price
86.60USD
Spread / Average Target
+10.32%

Quarterly revenue - Rate of surprise